Abstract:The use of recombinant human bone morphogenetic protein -2 (rhBMP-2) to induce ectopic bone formation requires a carrier. Atelocollagen, a biomaterial with a porous structure, excellent operational features and biocompatibility, is known to be an effective carrier for rhBMP-2. However, conventionally used lyophilized rhBMP-2/atelocollagen mixture does not necessarily give adequate bone induction effect. In the present study, we evaluated the effect of immobilizing rhBMP-2 to succinylated type I atelocollagen on the cellular activity of ST2 cells and immobilized rhBMP-2/ atelocollagen and non immobilized rhBMP-2/atelocollagen implanted in subcutaneous pockets of Wister rats. Our results revealed that 1) Alkaline phosphatase activity confirmed the effectiveness of rhBMP-2/ succinylated type I atelocollagen immobilization in augmenting cellular activity. 2) Intracellular signaling continued for prolonged period when rhBMP-2 was immobilized to succinylated type I atelocollagen. 3) In rhBMP-2/atelocollagen implants were completely fully with new bone formation and cell proliferation. Whereas, in non immobilized rhBMP-2/atelocollagen implants showed new hard tissue in the periphery of the carrier with only collagen membrane in its center. This study indicated that immobilizing rhBMP-2 is an efficient method to increase bone induction.
Introduction
About twenty types of bone morphogenetic proteins (BMP) have been reported within the BMP family. [1] [2] [3] Among them, BMP-2 possesses the strongest bone inducing activity, and basic research has been conducted aiming at clinical application of this protein. [4] [5] [6] [7] A carrier is indispensable when using rhBMP-2 to induce ectopic bone formation. Basic research has indicated that the atelocollagen, a biomaterial with a porous structure and excellent operational features and biocompatibility is highly effective as a carrier for rhBMP-2. [8] [9] [10] However, these studies used a lyophilized rhBMP-2/atelocollagen mixture, which may not possess an adequate bone induction effect. The mechanism of action of immobilized rhBMP-2 on cells is based on the theories of biomaterial science with respect to chemically bonding the ligand rhBMP-2 to a carrier. The ligand-carrier composite will react with the receptors on target cells and initiate the cellular function control mechanism. When growth factors such as insulin like growth factor and epithelial cell growth factor are immobilized to a carrier, the immobilized growth factor binds with the receptor on the cell surface forming a complex. [11] [12] [13] [14] [15] [16] Without being internalized into the cell, the growth factor-receptor complex is able to transduce signals into the cell over a long period of time, achieving high efficiency in promoting cell proliferation. BMP family is considered to be differentiation factors. 17 However, the effects of immobilized rhBMP-2 on cell differentiation and augmentation of cellular activity remain unknown. The purpose of this study was to test the hypothesis that chemically bonding (immobilizing) rhBMP-2 to atelocollagen may improve cell activity in vitro and increase the bone induction effect in vivo.
The cells were seeded in 10 cm petridishes (Falcon, Inc., USA) at a cell density of 2x10 5 Chemical, Inc., Japan) was used. The principle of rhBMP-2/ succinylated type I atelocollagen immobilization using WSC is illustrated in (Fig. 1 ).
18 .
The test samples were prepared by the following methods: A.
Immobilized group: succinylated type I atelocollagen 3 mg/ml was dissolved in dilute hydrochloric acid with pH 3.0. As a pre- Total RNA was extracted from the cultured cells according to the AGPC method 20 using TRIzol (Life Technologies, Inc., USA). 
Subcutaneous implantation and explantation
Wister Rats were subjected to intramuscular anesthesia with Ketamine (Fuji Chemical Industry Co., Ltd. Japan) and Dormitol (Meiji Seika Kaisha LTD. Japan). The samples contained 10mg of type I atelocollagen and 10µg of rhBMP-2. On the subcutaneous pockets of the back immobilized rhBMP-2/atelocollagen and non immobilized rhBMP-2/atelocollagen were implanted. The animals were sacrificed with an overdose of ether at 2 weeks after implantation. All specimens and surrounding tissue were removed and fixed by 4% paraformaldehyde, decalcified with 10% EDTA, embedded in paraffin, sectioned at 4 µm in thickness and stained by hematoxylin-eosin (H&E).
Results
Effect of immobilized rhBMP/succinylated type I atelocollagen on ST2 cells
ALP activity with time course
Compared to the collagen control group, both the immobilized and non-immobilized groups showed increased ALP activity along of the period of time. The immobilized and non-immobilized groups showed no differences in ALP activity on days 1 and 3, but significantly higher ALP activity was observed in the immobilized group compared to the non-immobilized group on days 5 and 7 (Fig. 2) . 
RT-PCR
The changes in gene expression detected by quantitative RT-PCR at various times after the addition of immobilized or nonimmobilized rhBMP-2 are shown in fig. 3 .
Expression of BMPR-1A gene
In the immobilized group, the expression remained unchanged after the addtion of immobilized rhBMP-2 for up to 24 h, and then decreased at 48 h. In the non-immobilized group, the expression decreased sharply after the addition of nonimmobilized rhBMP-2, but started to increase with time after 3 h.
Expression of specific Smad 1, 5 and 8 genes
In the immobilized group, the expression remained almost unchanged after the addition of immobilized rhBMP-2 but decreased after 48 h. In the non-immobilized group, an early, sharp decrease in expression was observed after the addition of non-immobilized rhBMP-2, and thereafter gene expression started to increase with time.
The pattern of expression for Smad 8 gene differed from those of Smad 1 and 5. In the immobilized group, the expression increased along of period of time, reaching a peak at 12 h and declined thereafter. In the non-immobilized group, the expression continued to increase with time.
Expression of inhibitory Smad 6 and 7 genes
In the immobilized group, there was a sharp increase with time, and the high level of expression was maintained, followed by a decrease after 48 h. In the non-immobilized group, the Smad 6 gene expression showed a tendency to increase with time continuously, but Smad 7 gene expression reached a maximum at 3 h followed by a decline in its expression.
Expression of BMP-4 gene
In the immobilized group, there was no remarkable change up to 6 h after the addition of immobilized rhBMP-2, but the expression increased at 12 h and then declined rapidly at 48 h. In the non-immobilized group, BMP-4 gene expression increased sharply at 1 h, declined at 3 h, and then increased with time. No BMP-2 and BMPR-IB gene expression was observed.
Histological Analysis
Immobilized rhBMP-2/atelocollagen showed the carriers fully filled by immature new bone with high cellularity. The new hard tissue was observed at the periphery and the center area of the carrier. Cellular proliferation was found in its center.
Non-immobilized rhBMP-2/atelocollagen revealed immature bone formation in the periphery of the carrier. In the center of carrier, only collagen membranes were observed. (Fig. 4) . hard tissue at the carrier periphery with only collagen membrane of the carriers in its center.
In conclusion, our results showed that intracellular signaling continued for prolonged period when rhBMP-2 was immobilized to succinylated type I atelocollagen. Moreover, immobilized rhBMP-2 stimulated alkaline phosphatase activity by ST2 cells in vitro and increase the bone induction in vivo . Because of this, we believe that immobilizing rhBMP-2 is an efficient method to increase bone induction.
